• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Shilpa Medicare Limited — Updates, 30-06-2026: Press Release

    30-06-2026 | 10:23 am

    Shilpa Biologicals partnered with Orion to co-develop and supply a Nivolumab biosimilar for Europe. Shilpa will lead development & manufacturing, earning milestone payments and supply revenue from this significant ~$4.1 billion market.

    No comments yet. Be the first to comment!

    All announcements from Shilpa Medicare Limited